SCHEMBL5260700

SCHEMBL5260700

CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3CCN3CCN(C)CC3)c2)n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 20/20 0.72
KDR P35968 14/20 0.66
LCK P06239 2/20 0.66
AURKA O14965 1/20 0.66
ABL1 P00519 1/20 0.66
EGFR P00533 1/20 0.66
NTRK1 P04629 1/20 0.66
INSR P06213 1/20 0.66
FES P07332 1/20 0.66
CSF1R P07333 1/20 0.66
LYN P07948 1/20 0.66
RET P07949 1/20 0.66
IGF1R P08069 1/20 0.66
MET P08581 1/20 0.66
PDGFRB P09619 1/20 0.66
FGR P09769 1/20 0.66
SRC P12931 1/20 0.66
AKT1 P31749 1/20 0.66
CSK P41240 1/20 0.66
ZAP70 P43403 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1267808 0.94 TEK (0.73) TEKKDRLCKAURKAABL1
SCHEMBL1264142 0.88 TEK (0.89) TEKKDRLCKAURKAABL1
SCHEMBL5264723 0.88 TEK (0.80) TEKKDRLCKAURKAABL1
SCHEMBL1265611 0.86 TEK (0.77) TEKKDRLCKAURKAABL1
SCHEMBL1265203 0.86 TEK (0.76) TEKKDRLCKAURKAABL1
SCHEMBL1264966 0.85 TEK (0.68) TEKKDRLCKAURKAABL1
SCHEMBL1265846 0.85 TEK (0.68) TEKKDRLCKAURKAABL1
SCHEMBL1264508 0.85 TEK (0.72) TEKKDRLCKAURKAABL1
SCHEMBL1265190 0.84 TEK (0.72) TEKKDRLCKAURKAABL1
SCHEMBL12422655 0.84 TEK (0.99) TEKKDRLCKAURKAABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751136-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2007-02-14 EP claimed
WO-2005113494-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2005-12-01 WO claimed